LifeStance Health公布2024年第四季度财报:GAAP EPS为$(0.01),超出预期销量达3.255亿美金

财报速递2025-02-27
LifeStance Health Gr (NASDAQ:LFST)报告季度每股亏损$(0.01),好于分析师一致预期的$(0.04),超出75%。与去年同期每股亏损$(0.12)相比增加了91.67%。公司报告季度销售额为3.255亿美元,超出分析师一致预期的3.1372亿美元,超出3.75%。与去年同期的2.806亿美元的销售额相比,增长了16.00%。

以上内容来自Benzinga Earnings专栏,原文如下:

LifeStance Health Gr (NASDAQ:LFST) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0.04) by 75 percent. This is a 91.67 percent increase over losses of $(0.12) per share from the same period last year. The company reported quarterly sales of $325.50 million which beat the analyst consensus estimate of $313.72 million by 3.75 percent. This is a 16.00 percent increase over sales of $280.60 million the same period last year.

免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白
发表看法